delcath systems inc nasdaq dcth publicly traded specialty pharmaceutical medical device develops percutaneous perfusion technologies targeted administration highdose chemotherapeutic agents specific organs regions body based queensbury new york company intellectual property portfolio consisting patents worldwide delcaths percutaneous hepatic perfusion php currently undergoing phase ii phase iii trials tumors delcath cooperative research development agreement crada national cancer institute received fast track special protocol assessment food drug administration use melphalan treating unresectable liver tumors php also known delcath system tested treatment metastatic melanoma liver primary liver cancer metastatic hepatic malignancies neuroendocrine cancers well patients melanoma previously received isolated perfusion chemotherapy usually delivered intravenously although number agents administered orally eg specialty drugs melphalan trade name alkeran busulfan oncology article stub help wikipedia expanding article medical pharmaceutical biotechnological corporation company stub help wikipedia expanding ithttpsenwikipediaorgwikidelcathsystems